EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methylphenidate-related cardiac and cardiovascular safety: a bibliometric and network analysis ​

ÖMER ÇAĞLAR YILMAZ, SADETTİN BURAK AÇIKEL

Turkish Journal of Medical Sciences · 15.10.2026 · 56 (5) · 1574-1587

DOI: 10.55730/1300-0144.6403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 15.10.2026. Verfasst von ÖMER ÇAĞLAR YILMAZ und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

​ Background/aim: Methylphenidate is widely used for the treatment of attention-deficit/hyperactivity disorder (ADHD); however, concerns regarding its cardiac and cardiovascular safety remain clinically relevant. This study aimed to delineate the scientific landscape of methylphenidate-related cardiac and cardiovascular safety using bibliometric methods. Materials and methods: The Science Citation Index Expanded, Social Sciences Citation Index, and Emerging Sources Citation Index were used to search the Web of Science Core Collection. A proximity-based search that combined terms related to methylphenidate, cardiovascular health, and safety/adverse events retrieved 263 records. There were 244 publications in the dataset after only including articles and reviews. VOSviewer was used to analyze author coauthorship, country coauthorship, keyword cooccurrence, and source citation networks.

Results

After author name disambiguation, author coauthorship analysis identified 34 authors in five clusters, with Coghill, Banaschewski, Buitelaar, Wong, McCarthy, and Sonuga-Barke showing the strongest collaborative links. The analysis of countries found 24 countries or regions in five clusters. The USA was the most productive country, and England had the strongest overall link strength. Keyword analysis found 33 standardized keywords in eight clusters. The most common words were “attention-deficit/hyperactivity disorder,” “methylphenidate,” “stimulants,” “atomoxetine,” and “amphetamines.” Source citation analysis showed that CNS Drugs received the highest number of citations, whereas the Journal of Child and Adolescent Psychopharmacology was the most productive source. Neurology showed a notable citation impact despite contributing only two documents.

Conclusion

The literature is structured around ADHD pharmacotherapy, cardiovascular surveillance, severe cardiac outcomes, drug safety, and pharmacoepidemiology. There is a need for more international cooperation and long-term studies that compare safety.

Zitieren

APA

YILMAZ, Ö. Ç., & AÇIKEL, S. B. (2026). Methylphenidate-related cardiac and cardiovascular safety: a bibliometric and network analysis ​. Turkish Journal of Medical Sciences, 56(5), 1574-1587. https://doi.org/10.55730/1300-0144.6403

Vancouver

YILMAZ ÖÇ, AÇIKEL SB. Methylphenidate-related cardiac and cardiovascular safety: a bibliometric and network analysis ​. Turkish Journal of Medical Sciences. 2026;56(5):1574-1587. doi:10.55730/1300-0144.6403

BibTeX
@article{YILMAZ2026,
  author = {YILMAZ, ÖMER ÇAĞLAR and AÇIKEL, SADETTİN BURAK},
  title = {Methylphenidate-related cardiac and cardiovascular safety: a bibliometric and network analysis ​},
  journal = {Turkish Journal of Medical Sciences},
  year = {2026},
  volume = {56},
  number = {5},
  pages = {1574--1587},
  doi = {10.55730/1300-0144.6403}
}
Kostenlos starten →